The antidiabetic and anti-obesity potential was investigated spectrophotometrically in vitro by the ability to modulate pancreatic lipase and α-glucosidase at different concentrations using orlistat and acarbose as reference drugs. This evidence concerns the gene PNLIP and obesity due to melanocortin 4 receptor deficiency.